Australian Prescriber Podcast podcast

E168 - New and emerging drug therapies for Alzheimer disease

0:00
19:22
Rewind 15 seconds
Fast Forward 15 seconds

David Liew speaks with geriatrician and dementia specialist Louise Waite about her article on new and emerging therapies for Alzheimer disease. Louise explains key biomarkers for Alzheimer disease, and the potentially disease-modifying monoclonal antibody therapies that have been approved by the FDA and are now being considered by the TGA in Australia. Read the full article by Louise in Australian Prescriber.

More episodes from "Australian Prescriber Podcast"